// App-Quantinova.ai

884 : Changes in Lipid Levels and Incidence of Cardiovascular Events Following Tofacitinib Treatment in Patients with Psoriatic Arthritis: An Integrated Analysis across Phase 3 and Long-Term Extension Studies

Researchers

Presenter

  • Dafna D Gladman

Principal Investigators

  • Christina Charles-Schoeman

  • Iain B. McInnes

  • Douglas J. Veale

  • Bruce Thiers

  • Daniela Graham

  • Cunshan Wang

  • Thomas Jones

  • Robert Wolk

  • Ryan DeMasi

Medical Centers

  • Department of Medical Imaging, University of Toronto, Toronto General Hospital, Toronto, ON, Canada

  • University of California, Los Angeles, Los Angeles, CA

  • Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom

  • St Vincents University Hospital and University College Dublin, Dublin, Ireland

  • Medcl Univ of South Carolina, Charleston, SC

  • Pfizer, Groton, CT

  • Pfizer Inc, Collegeville, PA

Locations

  • Canada

  • United States

  • United Kingdom

  • Ireland

Companies

  • Pfizer Inc.

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Tasocitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved